The currently identified RNF168 allele (c.640_644del5, Lys214Terfs, rs777601326) was observed in 4/247 (1.6%) of the Northern Finnish hereditary cases, but it was also detected in 6/1185 (0.5%) of the controls and showed only a borderline association with breast cancer susceptibility (p = 0.077, OR = 3.2 and 95% CI = 0.9–11.5) (Table 1). Here, RNF168 is linked to breast carcinoma.